Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 18 Mui/0.6 ml ROFERON A 18 Mui/0.6 ml ROCHE ROMANIA S.R.L.
ROFERON A 3 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 4.5 Mui/0.5 ml ROFERON A 4.5 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 9 Mui/0.5 ml ROFERON A 9 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 3 Mui/0.5 ml ROFERON A 3 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 4.5 Mui/0.5 ml ROFERON A 4.5 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 9 Mui/0.5 ml ROFERON A 9 Mui/0.5 ml ROCHE ROMANIA S.R.L. ________________________________________________________________________________
| 398 |L03AB05| INTERFERONUM ALFA 2b**** | Protocol: J006N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZĂ 18 milioane U.I. INTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE
INTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
INTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE ________________________________________________________________________________ ______________________________________________________________________________ | 399 |L03AB10| PEGINTERFERON alfa-2b**** | Protocol: J003N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. 100 µg INJ. PEGINTRON 100 µg 100 µg SP EUROPE L03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. 120 µg INJ.
PEGINTRON 120 µg 120 µg SP EUROPE L03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. 150 µg INJ.
PEGINTRON 150 µg 150 µg SP EUROPE L03AB10 PEGINTERFERON alfa-2b PULB. + SOLV. PT. SOL. 50 µg INJ.
PEGINTRON 50 µg 50 µg SP EUROPE ________________________________________________________________________________ ______________________________________________________________________________ | 400 |L03AB11| PEGINTERFERON alfa-2a**** | Protocol: J004N | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AB11 PEGINTERFERON alfa-2a SOL. INJ. 135 µg/ml PEGASYS 135 µg/ml 135 µg/ml ROCHE REGISTRATION LTD.
PREUMPLUTĂ PEGASYS 180 µ/0,5 ml 180 µ/0.5 ml ROCHE REGISTRATION LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 401 |N04BB01| AMANTADINUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ N04BB01 AMANTADINUM CAPS. 100 mg VIREGYT(R)-K 100 mg EGIS PHARMACEUTICALS LTD. ________________________________________________________________________________ SUBLISTA C1 - G5 HEPATITA AUTOIMUNĂ. ______________________________________________________________________________ | 402 |H02AB04| METHYLPREDNISOLONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 125 mg LEMOD SOLU 125 mg 125 mg HEMOFARM S.R.L
SOL. INJ. SOLU - MEDROL ACT-O-VIAL 125 mg/2 ml PFIZER EUROPE MA EEIG
MEDROL A 16 16 mg PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 20 mg LEMOD SOLU 20 mg 20 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. 250 mg/4 ml SOL. INJ. SOLU - MEDROL ACT-O-VIAL 250 mg/4 ml PFIZER EUROPE MA EEIG
MEDROL 32 32 mg PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 40 mg LEMOD SOLU 40 mg 40 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. 40 mg/1 ml SOL. INJ. SOLU - MEDROL ACT-O-VIAL 40 mg/1 ml PFIZER EUROPE MA EEIG
MEDROL 4 mg 4 mg PFIZER EUROPE MA EEIG H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 500 mg LEMOD SOLU 500 mg 500 mg HEMOFARM S.R.L. H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. 500 mg/7.8 ml INJ.
SOLU - MEDROL 500 mg/7,8 ml 500 mg/7.8 ml PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 403 |H02AB06| PREDNISOLONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. 250 mg INJ. SOLU - DECORTIN H 250 250 mg MERCK KGAA H02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. 50 mg INJ.
SOLU - DECORTIN H 50 50 mg MERCK KGAA ________________________________________________________________________________ ______________________________________________________________________________ | 404 |L04AX01| AZATHIOPRINUM* | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg IMURAN(R) 50 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ SUBLISTA C1 - G06 CIROZA BILIARĂ PRIMARĂ, COLANGITA SCLEROZANTĂ PRIMITIVĂ, HEPATITA CRONICĂ ŞI CIROZE DE ALTE ETIOLOGII CU COLESTAZĂ. ______________________________________________________________________________ | 405 |A05AA02| ACIDUM URSODEOXYCHOLICUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A05AA02 ACIDUM CAPS. 300 mg URSODEOXYCHOLICUM URSOFALK(R) 250 mg DR. FALK PHARMA GMBH URSOFALK(R) 250 mg DR. FALK PHARMA GMBH URSOSAN 250 mg PRO. MED. CS PRAHA AS ________________________________________________________________________________
| 406 |A06AD11| LACTULOSUM* | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A06AD11 LACTULOSUM LICHID ORAL 66.7% DUPHALAC(R) 66.7% SOLVAY PHARMACEUTICALS BV
LACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG A06AD11 LACTULOSUM LAEVOLAC 670 mg/ml 670 mg/ml FRESENIUS KABI AUSTRIA GMBH
LACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG A06AD11 LACTULOSUM SOL. ORALĂ 670 mg/ml LAEVOLAC 670 mg/ml 670 mg/ml FRESENIUS KABI AUSTRIA GMBH
LACTULOSE AL SIROP 66.7% ALIUD PHARMA GMBH & CO.KG A06AD11 LACTULOSUM SOL. ORALĂ 670 mg/ml LAEVOLAC 670 mg/ml 670 mg/ml FRESENIUS KABI AUSTRIA GMBH
DUPHALAC(R) 66.7% SOLVAY PHARMACEUTICALS BV A06AD11 LACTULOSUM SIROP 65% LACTULOSE 65% E.I.P.I.CO. MED S.R.L. ________________________________________________________________________________
| 407 |A07AA11| RIFAXIMINUM* | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A07AA11 RIFAXIMINUM COMPR. FILM. 200 mg NORMIX 200 mg 200 mg ALFA WASSERMANN SPA ________________________________________________________________________________ #M4 ______________________________________________________________________________ | 408 | *** Abrogată | |_______|______________________________________________________________________| ______________________________________________________________________________ | 409 | *** Abrogată | |_______|______________________________________________________________________| #B ______________________________________________________________________________ | 410 |C03CA01| FUROSEMIDUM | | |_______|_______|____________________________________________|_________________| Electroliţii serici trebuie să fie verificaţi periodic. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C03CA01 FUROSEMIDUM SOL. INJ. 10 mg/ml FUROSEMID 20 mg/2 ml 10 mg/ml ZENTIVA SA
FUROSEMID ARENA 40 mg 40 mg ARENA GROUP S.A. FUROSEMID EEL 40 mg BIO EEL SRL FUROSEMID LPH 40 mg 40 mg LABORMED PHARMA SA FUROSEMID MCC 40 mg 40 mg MAGISTRA C & C SRL FUROSEMID SLAVIA 40 mg SLAVIA PHARM SRL FUROSEMID ZENTIVA 40 mg ZENTIVA SA ________________________________________________________________________________ ______________________________________________________________________________ | 411 |C03DA01| SPIRONOLACTONUM | | |_______|_______|____________________________________________|_________________|
Femeile la vârsta fertilă la care s-a iniţiat tratament cu spironolactonă trebuie să ia măsuri adecvate de contracepţie. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C03DA01 SPIRONOLACTONUM CAPS. 100 mg VEROSPIRON 100 mg GEDEON RICHTER LTD.
SPIRONOLACTONA 25 mg 25 mg BIO EEL SRL C03DA01 SPIRONOLACTONUM COMPR. FILM. 25 mg ALSPIRON 25 mg 25 mg AC HELCOR PHARMA SRL SPIRONOLACTONA 25 mg 25 mg TERAPIA SA
VEROSPIRON 50 mg GEDEON RICHTER LTD. C03DA01 SPIRONOLACTONUM COMPR. FILM. 50 mg ALSPIRON 50 mg 50 mg AC HELCOR PHARMA SRL ________________________________________________________________________________
| 412 |H02AB06| PREDNISOLONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. 250 mg INJ. SOLU - DECORTIN H 250 250 mg MERCK KGAA H02AB06 PREDNISOLONUM LIOF. + SOLV. PT. SOL. 50 mg INJ.
SOLU - DECORTIN H 50 50 mg MERCK KGAA ________________________________________________________________________________ ______________________________________________________________________________ | 413 |J05AB04| RIBAVIRINUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB04 RIBAVIRINUM CAPS. 200 mg REBETOL 200 mg 200 mg SP EUROPE
COPEGUS(R) 200 mg ROCHE ROMANIA SRL ________________________________________________________________________________
| 414 |J05AF05| LAMIVUDINUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AF05 LAMIVUDINUM COMPR. FILM. 100 mg ZEFFIX 100 mg 100 mg GLAXO GROUP LTD.
EPIVIR 10 mg/ml 10 mg/ml GLAXO GROUP LTD. J05AF05 LAMIVUDINUM COMPR. FILM. 150 mg EPIVIR 150 mg 150 mg GLAXO GROUP LTD. J05AF05 LAMIVUDINUM SOL. ORALĂ 5 mg/ml ZEFFIX 5 mg/ml 5 mg/ml GLAXO GROUP LTD. ________________________________________________________________________________
| 416 |J05AF10| ENTECAVIRUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AF10 ENTECAVIRUM COMPR. FILM. 0,5 mg BARACLUDE 0,5 mg 0,5 mg BRISTOL-MYERS SQUIBB PHARMA EEIG J05AF10 ENTECAVIRUM COMPR. FILM. 1 mg BARACLUDE 1 mg 1 mg BRISTOL-MYERS SQUIBB PHARMA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 417 |L03AA02| FILGRASTIMUM (G-CSF)** | Protocol: B013K | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AA02 FILGRASTIMUM (G-CSF) SOL. INJ. 30 MU/0.5 ml NEUPOGEN(R) 30 MU/0.5 ml AMGEN EUROPE B.V.
NEUPOGEN(R) 48 MU/0.5 ml AMGEN EUROPE B.V. ________________________________________________________________________________
| 418 |L03AB04| INTERFERONUM ALFA 2a**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 18 Mui/0.6 ml ROFERON A 18 Mui/0.6 ml ROCHE ROMANIA S.R.L.
ROFERON A 3 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 4.5 Mui/0.5 ml ROFERON A 4.5 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 9 Mui/0.5 ml ROFERON A 9 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 3 Mui/0.5 ml ROFERON A 3 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 4.5 Mui/0.5 ml ROFERON A 4.5 Mui/0.5 ml ROCHE ROMANIA S.R.L. L03AB04 INTERFERONUM ALFA 2a SOL. INJ. 9 Mui/0.5 ml ROFERON A 9 Mui/0.5 ml ROCHE ROMANIA S.R.L. ________________________________________________________________________________
| 419 |L03AB05| INTERFERONUM ALFA 2b**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AB05 INTERFERONUM ALFA 2b SOL. INJ. PEN MULTIDOZĂ 18 milioane U.I. INTRON A 18 milioane U.I. 18 milioane U.I. SP EUROPE
INTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE
INTRON A 30 milioane U.I. 30 milioane U.I. SP EUROPE INTRON A 60 milioane U.I. 60 milioane U.I. SP EUROPE ________________________________________________________________________________ ______________________________________________________________________________ | 420 |L03AB10| PEGINTERFERON alfa-2b**** | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|